MBCL-46. TREATMENT OF RECURRENT WINGLESS-ACTIVATED MEDULLOBLASTOMA (Wnt-MB) INCORPORATING MARROW-ABLATIVE THIOTEPA AND CARBOPLATIN CHEMOTHERAPY (HDCx) AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (AuHPCR): A DUAL REPORT

BACKGROUND: Wnt-MB infers an excellent prognosis, and metastatic disease is rare. However, specific treatment strategies and patterns of failure for patients with recurrent Wnt-MB are unknown. We report two cases of recurrent beta-catenin nucleopositive Wnt-MBs treated with an irradiation-sparing st...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Micah K, Funk, Zachary N, Boué, Daniel R, Pierson, Christopher R, Jones, Jeremy, Leonard, Jeffrey, Abu-Arja, Rolla, Auletta, Jeffrey, Osorio, Diana S, Shatara, Margaret, Paul, Stephan R, Finlay, Jonathan L, AbdelBaki, Mohamed S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715265/
http://dx.doi.org/10.1093/neuonc/noaa222.517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715265/
http://dx.doi.org/10.1093/neuonc/noaa222.517

Ejemplares similares